Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)
The purpose of this Notice of Amendment is to notify that Health Canada will add Epinephrine topical solution for hemostasis when sold at a concentration equal to or greater than 1 mg/ml (1:1000) to the Prescription Drug List (PDL). Both the Human and the Veterinary parts of the PDL were revised.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)HTMLEnglish publication HTML
-
Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)HTMLFrench publication HTML
Similar records